Drug, supplement component "import for export" allowed with notification, records -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
NON-U.S. APPROVED USES OF EXPORTED DRUGS REQUIRE SPECIAL LABELING statement in the language of the foreign country in which the product is marketed, FDA determines in a draft guidance published in the June 12 Federal Register. Information about uses unapproved in the U.S. also should be accompanied by a statement on the labeling noting that fact, the agency suggests in its "Draft Guidance for Industry on Exports and Imports Under the FDA Export Reform and Enhancement Act of 1996."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning